Key facts
- 3Aware’s last known valuation is $24.0M (Jan 2024).
- It has raised $12.3M across 3 recorded rounds; the latest was Seed Round ($2.4M) in Jan 2024.
- Notable investors include Oakwood Circle Ventures, Cook Medical, Health Cloud Capital, NWS Holdings (United States), VisionTech Partners.
- 3Aware has filed 2 Form Ds with the SEC, most recently Jan 2024 ($2.4M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for 3Aware
Funding rounds
3 roundsAbout 3Aware
Developer of medical devices designed for immediate access to clinical data. The company's platform equips medtech manufacturers to access real-world data and independently analyze patients, encounters, and devices for reporting, quickly and affordably, enabling manufacturers to get medical records to fulfill food and drug administration post-approval studies, as well as meet regulatory requirements, equipping them with future regulatory development.
- Sector
- Healthcare
- HQ
- Indianapolis, IN, United States
- Founded
- 2022
- Employees
- 30
- Website
- 3aware.ai/
- Ownership
- Privately Held (backing)
3Aware doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 3Aware shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 3Aware in its N-PORT filings yet. We sweep new filings monthly.